Search For "moderna"
Moderna CEO advocates 3rd vaccine dose to protect people at risk
Updated : 4 years, 10 months ago IST
Moscow [Russia], May 23 (ANI/Sputnik): Vaccination with a booster shot among as many people as possible is a good way to protect those most at risk against ever-emerging new coronavirus variants, Moderna CEO Stephane Bancel said on Sunday.
Read More
Japan to approve use of AstraZeneca, Moderna COVID-19 vaccines
Updated : 4 years, 10 months ago IST
Tokyo [Japan], May 21 (ANI): The Japanese government on Friday gave the green signal for two more COVID-19 vaccines -- those developed by AstraZeneca and Moderna pharmaceutical giants -- to be added to the nation's vaccine portfolio, Kyodo news reported.
Read More
Both Pfizer, Moderna vaccines effective on B.1.617 COVID-19 strain: US Stu
Updated : 4 years, 10 months ago IST
Washington [US], May 19 (ANI): COVID-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study.
Read More
COVID-19: Japan's health ministry to authorise use of Moderna vaccine
Updated : 4 years, 10 months ago IST
Tokyo [Japan] May 18 (ANI): Japan's health ministry is set to authorize the use of Moderna's vaccine against coronavirus later this week.
Read More
Pfizer, Moderna vaccines effective against Covid variants found in India:
Updated : 4 years, 10 months ago IST
New Delhi [India] May 18, (ANI): The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against COVID variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper, which has not yet been peer-reviewed, CNN reported.
Read More
WHO gives Emergency Use Authorisation to Moderna's COVID jab
Updated : 4 years, 10 months ago IST
Geneva [Switzerland], May 1 (ANI): The World Health Organization (WHO) on Friday listed the Moderna coronavirus vaccine for emergency use, adding another shot to its arsenal in the fight against the coronavirus.
Read More
Moderna to supply twice as many than planned COVID vaccine doses in 2022
Updated : 4 years, 10 months ago IST
New York [US], April 29 (ANI/Sputnik): US pharmaceutical company Moderna seeks to supply 3 billion vaccine doses against COVID-19 in 2022 instead of 1.4 billion, which is twice as many than planned, according to the company's statement, published on Thursday.
Read More
Pfizer, Moderna COVID-19 vaccines 'do not appear to pose serious risk' dur
Updated : 4 years, 11 months ago IST
Washington [US], April 22 (ANI): The mRNA Covid-19 vaccines by Pfizer/BioNTech and Moderna do not appear to pose any serious risk during pregnancy, according to new data published Wednesday in the New England Journal of Medicine.
Read More
Risk of rare blood clots higher after Covid-19 infection than after vaccin
Updated : 4 years, 11 months ago IST
London [UK], April 16 (ANI): Researchers at Oxford University have found the risk of a rare type of blood clot is low overall, but higher for people who have been infected with Covid-19 than among people who've had the three vaccines authorized in the UK - those made by AstraZeneca, Moderna
Read More
UK study into mixing COVID-19 vaccines to include Novavax, Moderna jabs
Updated : 4 years, 11 months ago IST
London [UK], April 14 (ANI): As the rollout of the Johnson and Johnson coronavirus vaccine has been paused in the United States, the European Union and South Africa, Researchers in Britain investigating the effects of using one coronavirus vaccine for a first dose and another for a second ha
Read More
Study finds Moderna's COVID-19 vaccine 90 pc effective six months after se
Updated : 4 years, 11 months ago IST
New York [US], April 14 (ANI): Moderna announced on Tuesday (local time) that their coronavirus vaccine was 90 per cent effective six months after a person receives their second dose.
Read More
COVID-19: US begins study assessing allergic reactions to Pfizer, Moderna
Updated : 4 years, 11 months ago IST
Washington [US], April 8 (ANI): US' National Institutes of Health (NIH) announced on Wednesday that it is launching a study to determine the risk of allergic reactions to the Pfizer-BioNTech and Moderna vaccines among certain individuals.
Read More